Systemic Steroids: Uses, Effects, and Safety
Comprehensive guide to systemic corticosteroids: mechanisms, applications, side effects, and safe management in dermatology.

What Are Systemic Steroids?
Systemic steroids, also known as corticosteroids, are synthetic derivatives of cortisol, a natural steroid hormone produced by the adrenal glands. When taken orally or administered by intramuscular injection, these medications exert profound anti-inflammatory effects throughout the body. Unlike topical steroids applied directly to the skin, systemic steroids work internally to suppress inflammation and immune responses.
Systemic steroids function by mimicking the regulatory mechanisms of natural cortisol, affecting multiple physiological systems. Cortisol normally regulates protein, carbohydrate, lipid, and nucleic acid metabolism, as well as inflammation, immune response, electrolyte distribution, and the secretion of adrenocorticotropic hormone (ACTH) from the pituitary gland. When administered therapeutically, systemic steroids replicate and amplify these effects to control severe inflammatory skin conditions.
Mechanisms of Action
Systemic steroids work in the same way as the body’s natural cortisol by suppressing the immune system and reducing inflammation. They regulate:
- Protein, carbohydrate, lipid, and nucleic acid metabolism
- Inflammatory and immune responses
- Distribution and excretion of water and electrolytes
- Secretion of hormones from the pituitary gland
Different systemic steroids vary in their potency, mineralocorticoid activity, duration of action, and ability to suppress the hypothalamic-pituitary-adrenal (HPA) axis. The HPA axis controls the body’s production of natural cortisol, so suppression of this system can reduce the adrenal glands’ ability to produce endogenous steroids.
Clinical Applications in Dermatology
Acute Dermatoses
Systemic steroids are prescribed for acute severe skin diseases that require rapid control. Common acute conditions include:
- Plant contact allergies and contact dermatitis
- Autosensitisation dermatitis
- Acute flares of atopic dermatitis
- Sweet disease
- Drug hypersensitivity syndrome
- Acute urticaria (when antihistamines are ineffective)
For acute contact dermatitis, systemic steroids can be discontinued as soon as the rash is controlled (approximately 7 to 10 days) if the patient is no longer in contact with the allergen. In extensive or symptomatic lichen planus, systemic steroids may be used initially to gain control before transitioning to other treatments.
Chronic Dermatoses
Chronic autoimmune skin conditions should only be treated with systemic steroids after careful consideration of the risk-benefit ratio and when resistant to other medications. Appropriate chronic conditions may include:
- Autoimmune bullous diseases
- Systemic lupus erythematosus
- Severe pemphigus and pemphigoid
- Other steroid-responsive autoimmune dermatoses
Importantly, systemic steroids are best avoided in psoriasis, as they can complicate disease control, particularly after steroid withdrawal. In rare cases of severe psoriasis, they may be necessary but should only be prescribed under experienced dermatologist supervision.
Dosing Protocols
Short-Term Treatment
For acute dermatoses, an adult patient should typically be treated with 40 mg of prednisone daily, continued as long as necessary to control the skin disease properly, then tapered gradually. For acute contact dermatitis, this course usually lasts 7 to 10 days. Other forms of dermatitis and Sweet disease may require courses of three to four weeks.
Prednisone is best taken as a single dose in the morning, which reduces steroid-induced suppression of the pituitary-adrenal axis compared to evening dosing.
Long-Term Treatment
For chronic conditions requiring extended therapy, the starting dose is usually 40 mg of prednisone with breakfast for two to four weeks. If the disease is poorly controlled, the dose may be increased to 60 to 80 mg daily, but blood pressure, serum glucose, and side effects require careful monitoring.
Once the condition is controlled, the dose of steroids should be reduced by half for at least two weeks. Further reduction depends on the breakthrough dose, disease severity, and availability of steroid-sparing agents. The dose of long-term prednisone should be kept as low as possible, and ideally taken on alternate days.
Systemic Steroid Comparison
Different systemic steroids have varying potency levels and durations of action:
| Corticosteroid | Equivalent Dose (mg) | Mineralocorticoid Potency |
|---|---|---|
| Cortisone | 25 | 2+ |
| Hydrocortisone | 20 | 2+ |
| Prednisone | 5 | 1+ |
| Methylprednisolone | 4 | 0–0.5+ |
| Dexamethasone | 0.75 | 0 |
Prednisone remains the most commonly used oral corticosteroid in dermatology due to its balance of efficacy and tolerability.
Side Effects and Risks
Short-Term Side Effects
Side effects are rarely serious if systemic steroids are prescribed for one month or less. However, the following problems may arise, particularly with higher doses:
- Increased appetite
- Sleep disturbances and insomnia
- Mood changes and irritability
- Gastrointestinal symptoms
- Tremor
Rare and potentially serious side effects of short-term corticosteroid courses include:
- Acute adrenal insufficiency
- Severe infection
- Cardiovascular events
The risk of serious side effects increases with increasing dose.
Long-Term Side Effects
Treatment continuing for more than 3 months is regarded as long-term and results in the majority of undesirable side effects. Cutaneous adverse effects from long-term systemic steroids may include:
- Easy bruising and poor wound healing
- Steroid acne (acne-like eruption from high circulating corticosteroid levels)
- Skin atrophy
- Striae (stretch marks)
- Skin fragility
Systemic risks from long-term use include infections (bacterial, fungal, and viral), hypertension, diabetes, osteoporosis, avascular necrosis, myopathy, and glaucoma. The effects of systemic steroids on atherosclerotic vascular disease may result from complex metabolic changes, including alterations in lipid profiles and glucose metabolism.
Monitoring and Prevention Strategies
Bone Protection
If steroids are likely to be used for more than a few weeks, bone protection should be considered. Essential monitoring includes:
- Arrange a DEXA bone density scan at initiation of systemic steroids
- Prescribe calcium and vitamin D supplementation from the first day of treatment
- In high-risk individuals, consider a bisphosphonate from the outset
Systemic steroids stimulate bone resorption and reduce bone formation within the first few months of treatment, significantly increasing the risk of osteoporosis and fracture.
General Monitoring
Patients on systemic steroids require regular assessment and monitoring, including:
- Blood pressure checks
- Serum glucose monitoring
- Assessment for signs of infection
- Bone mineral density evaluation (at baseline and periodically)
- Ophthalmologic examination for glaucoma
- Monitoring for cardiovascular risk factors
Lifestyle Modifications
Several lifestyle measures can reduce steroid-associated risks:
- Weight-bearing exercise and physical activity
- Dietary measures to support bone health and metabolic control
- Blood pressure management through sodium restriction
- Diabetes prevention strategies
- Infection prevention measures
Patient Information and Counseling
Patients prescribed systemic steroids for skin diseases should be carefully advised of potential risks and adverse effects. Key patient education points include:
- The importance of taking medication as prescribed and not stopping abruptly
- Potential side effects and when to report them
- The necessity of dose tapering to allow adrenal function recovery
- The importance of regular monitoring appointments
- Infection prevention strategies
- Dietary recommendations, including calcium and vitamin D intake
- The importance of maintaining physical activity
- Recognition of signs requiring immediate medical attention
Dose Reduction and Discontinuation
Proper tapering of systemic steroids is essential to allow the adrenal glands to resume normal cortisol production. Abrupt discontinuation can lead to acute adrenal insufficiency. The rate of tapering depends on:
- Duration of treatment
- Total cumulative dose
- Underlying condition severity
- Availability of alternative therapies
Generally, doses are reduced gradually over weeks to months, with slower tapering for longer treatment courses. The maintenance dose should be kept as low as possible to minimize adverse effects.
Special Considerations
Intramuscular Administration
The use of intermittent intramuscular triamcinolone 40 to 80 mg has fallen out of favor. This route is more difficult to adjust dosages for, may produce side effects as troublesome as oral prednisone, and carries a relatively common complication of subcutaneous atrophy.
Risk Stratification
Risks from long-term systemic steroid effects refer specifically to patients treated with more than 7.5 mg/day of prednisone or equivalent doses for periods greater than 3 months. Below these thresholds, the risk of health effects is negligible.
Frequently Asked Questions
Q: Why are systemic steroids avoided in psoriasis?
A: Systemic steroids can make control of psoriasis very difficult, particularly after steroid withdrawal, potentially triggering severe rebound flares. In rare cases of severe psoriasis requiring systemic steroids, treatment should only proceed under experienced dermatologist supervision.
Q: How long does typical short-term steroid treatment last?
A: Treatment for less than one month is considered short-term. For acute contact dermatitis, courses typically last 7 to 10 days. Other forms of dermatitis may require 3 to 4 weeks of treatment.
Q: What is the standard starting dose of prednisone for acute dermatoses?
A: The standard adult starting dose is 40 mg of prednisone daily, taken as a single morning dose. This dose is continued as long as necessary to control the skin disease, then gradually tapered.
Q: Why should prednisone be taken in the morning?
A: Taking prednisone as a single morning dose is thought to reduce steroid-induced suppression of the pituitary-adrenal axis compared to evening dosing, helping preserve normal adrenal function.
Q: What monitoring is essential for long-term systemic steroid use?
A: Essential monitoring includes blood pressure, serum glucose, bone mineral density assessment via DEXA scan, ophthalmologic examination for glaucoma, and regular clinical evaluation for infections and other complications. Calcium and vitamin D supplementation should be prescribed from treatment initiation.
Q: Can systemic steroids be stopped suddenly?
A: No. Abrupt discontinuation of systemic steroids can lead to acute adrenal insufficiency. Doses must be gradually tapered to allow the adrenal glands to resume normal cortisol production, with tapering rates depending on treatment duration and total cumulative dose.
References
- Corticosteroids in Dermatitis — DermNet New Zealand. 2024. https://dermnetnz.org/cme/dermatitis/corticosteroids
- Systemic Steroids (Corticosteroids) — DermNet New Zealand. 2024. https://dermnetnz.org/topics/systemic-steroids
- Prophylactic Treatment for Dermatology Patients on Systemic Corticosteroid — DermNet New Zealand. 2024. https://dermnetnz.org/topics/prophylaxis-systemic-steroid
- Public Awareness of Side Effects of Systemic Steroids in Asir Region — National Center for Biotechnology Information. 2023. https://pmc.ncbi.nlm.nih.gov/articles/PMC10657041/
Read full bio of medha deb
















